Clinical Trials for NG BIOTECH

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases

A Study of FL115 Injection in Combination With a PD-1 Antibody in Advanced Solid Tumors

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM

CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

First-In-Human Study in Participants With Advanced Solid Tumors

Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011

DiagRaMIE Mpox Virus-RDC for the Diagnostic of Monkeypox

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/LBL

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

A Study of RD06-04 in Patients With Active Autoimmune Diseases

Phase 2 Study of WGI-0301 for Advanced HCC

iTear Single-center, Open-label, Single-arm Study

A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors

Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors

Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery

A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy